Search this Website

Skip to content

About Us
Our Work
Publications
Archives
- Clinical Trials
Photo Gallery
Contact
Support Us

CDSCO analysis reveals prevalence of substandard drugs in India

By admin Archives, Clinical Trials, General

Zachary Brennan | in-Pharma Technologist.com | 11-Mar-2014

Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO.

Read full article

Bookmark the permalink.

« Realizing the Right to Health Care

Kerala Government to Curb Unethical Practices in Clinical Trials »

Comments are closed.

What’s New

Training, Building Capacities and Leadership

Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

Research

Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

Advocacy

Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

Knowledge Creation

Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

About Us
Our Work
Publications
Archives
Photo Gallery
Contact
Support Us

© Sama – Resource Group for Women and Health, 2021

Powered by Parabola & WordPress.

Search for: